Oestradiol valerate pretreatment in GnRH-antagonist cycles: A randomized controlled trial

Reproductive BioMedicine Online

Volumn 24, Issue 3, 2012, Pages 272-280

  Blockeel, Christophe ^a   Engels, Sara ^a   De Vos, Michel ^a   Haentjens, Patrick ^b   Polyzos, Nikolaos P ^a   Stoop, Dominic ^a   Camus, Michel ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

GnRH antagonist; ICSI; Oestradiol valerate pretreatment; Ovarian stimulation; Reproductive endocrinology; Scheduling

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; GANIRELIX; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; EMBRYO CULTURE; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE INFERTILITY; MENSTRUAL CYCLE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS;

EID: 84857924648     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.11.012     Document Type: Article

References (30)

1. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception Cochrane Database Syst. Rev. 3 2006 CD001750
2. H.G. Al-Inany, M.A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, J. Smit, and A.M. Abou-Setta Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst. Rev. 11 2011 CD001750
3. C. Blockeel, A. Riva, M. De Vos, P. Haentjens, and P. Devroey Administration of a GnRH antagonist during 3 days before the initiation of the IVF/ICSI treatment cycle: impact on ovarian stimulation. A pilot study Fertil. Steril. 95 2011 1714 1719
4. I. Cédrin-Durnerin, B. Bständig, I. Parneix, V. Bied-Damon, C. Avril, C. Decanter, and J.N. Hugues Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol Hum. Reprod. 22 2007 109 116 (Pubitemid 44942673)
5. D. de Ziegler, A.S. Jääskeläinen, P.A. Brioschi, R. Fanchin, and C. Bulletti Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH) Hum. Reprod. 13 1998 561 564 (Pubitemid 28171945)
6. D. de Ziegler, P.A. Brioschi, C. Benchaa, A. Campana, P.J. Ditesheim, R. Fanchin, and C. Bulletti Programming ovulation in the menstrual cycle by a simple innovative approach: back to the future of assisted reproduction Fertil. Steril. 72 1999 77 82 (Pubitemid 29300265)
7. P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomàs, and B.C. Fauser Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum. Reprod. 24 2009 764 774
8. European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum. Reprod. 16 2001 644 651
9. R. Fanchin, L. Salomon, A. Castelo-Branco, F. Olivennes, N. Frydman, and R. Frydman Luteal estradiol pretreatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists Hum. Reprod. 18 2003 2698 2703 (Pubitemid 37536643)
10. R. Fanchin, L.M. Schonäuer, J.S. Cunha-Filho, D.H. Méndez Lozano, and R. Frydman Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation Semin. Reprod. Med. 23 2005 354 362 (Pubitemid 41740989)
11. F. Fischl, J.C. Huber, and A. Obruca Zeitliche optimierung der kontrollierten hyperstimulation (koh) in kombination mit gnrh-antagonisten und ovulationshemmer in einem ivf-programm J. Fertil. Reprod. 11 2001 50 51
12. D.K. Gardner, and W.B. Schoolcraft Culture and transfer of human blastocysts Hum. Reprod. 13 1999 3434 3440
13. R. Gómez, S.R. Soares, C. Busso, J.A. Garcia-Velasco, C. Simn, and A. Pellicer Physiology and pathology of ovarian hyperstimulation syndrome Semin. Reprod. Med. 28 2010 448 457
14. G. Griesinger, E.M. Kolibianakis, C. Venetis, K. Diedrich, and B. Tarlatzis Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonisy cycles: an updated meta-analysis Fertil. Steril. 94 2010 2382 2384
15. G. Griesinger, C.A. Venetis, T. Marx, K. Diedrich, B. Tarlatzis, and E.M. Kolibianakis Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis Fertil. Steril. 90 2008 1055 1063
16. A. Guivarc'h-Levêque, P. Arvis, J.-L. Bouchet, P.L. Broux, L. Moy, G. Priou, J. Vialard, and D. Colleu Efficacité de la programmation des cycles FIV en antagonists par les estrognes Gynécol. Obstét. Fertil. 38 2010 18 22
17. M.J. Hill, G.D. McWilliams, K.A. Miller, R.T. Scott Jr., and J.L. Frattarelli A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates Fertil. Steril. 91 2009 739 741
18. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod. Biomed. Online 18 2009 630 634
19. P. Humaidan, S. Kol, E. Papanikolaou on behalf of the 'The Copenhagen GnRH Agonist Triggering Workshop Group' GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum. Reprod. Update 17 2011 510 524
20. E.M. Kolibianakis, C. Albano, M. Camus, H. Tournaye, A. Van Steirteghem, and P. Devroey Prolongation of follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotrophin-releasing hormone antagonists Fertil. Steril. 82 2004 102 107 (Pubitemid 38968785)
21. E.M. Kolibianakis, C. Bourgain, E.G. Papanikolaou, M. Camus, H. Tournaye, A. Van Steirteghem, and P. Devroey Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement in the day of oocyte retrieval in GnRH antagonist cycles Hum. Reprod. 20 2005 2887 2892
22. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum. Reprod. Update 12 2006 651 671 (Pubitemid 44605507)
23. D. Meldrum, R. Scott, M.J. Levy, M.M. Alper, and N. Noyes A pilot study to assess oral contraceptive (OC) pre-treatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles Fertil. Steril. 78 2002 S176
24. E. Papanikolaou, E. D'Haeseleer, G. Verheyen, H. Van de Velde, M. Camus, A. Van Steirteghem, P. Devroey, and H. Tournaye Live birth is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture: a randomized prospective study Hum. Reprod. 20 2005 3198 3203 (Pubitemid 41662678)
25. E. Papanikolaou, C. Bourgain, E. Kolibianakis, H. Tournaye, and P. Devroey Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes Hum. Reprod. 20 2005 1541 1547 (Pubitemid 40852245)
26. B. Smulders, S.M. van Oirschot, C. Farquhar, L. Rombauts, and J.A. Kremer Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques Cochrane Database Syst. Rev. 1 2010 CD006109
27. B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, L. Rombauts, and P. Devroey GnRH antagonists in ovarian stimulation for IVF Hum. Reprod. Update 12 2006 333 340 (Pubitemid 43932048)
28. K.P. Tremellen, and M. Lane Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes Hum. Reprod. 25 2010 1219 1224
29. L. Van Landuyt, A. Devos, H. Joris, G. Verheyen, P. Devroey, and A. Van Steirteghem Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization process Fertil. Steril. 83 2005 1397 1403 (Pubitemid 40615811)
30. H. Ye, G.N. Huang, P.H. Zeng, and L. Pei IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long agonist protocol: a prospective and randomized study J. Assist. Reprod. Genet. 26 2009 105 111